COMPANY PROFILE

Precision Bio

Explore full profile

Precision biosensor, inc

Daejeon, South KoreaFounded 2015Health Tech & Medtech

Valuation $50–100M Last recorded · 2025

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Precision Bio

Precision Biosensor, Inc. is a prominent player in the Point of Care Testing (POCT) in vitro diagnostics market, focusing on the development, manufacturing, and global distribution of immunochromatography products. The company's flagship product, the Exdia TRF Analyzer, utilizes advanced imaging-based Time Resolved Fluorescence (TRF) technology to deliver precise and quantitative test results, crucial for critical care settings. This portable and user-friendly device ensures reliable diagnostics, with test assays compatible across all Exdia analyzers. The Exdia cassettes, which can be stored and transported at room temperature with a shelf life of 12 months, further enhance the product's convenience and usability. Precision Biosensor serves healthcare providers and institutions that require rapid and accurate diagnostic solutions, operating primarily in the medical diagnostics market. The business model revolves around the sale of diagnostic devices and consumables, generating revenue through both direct sales and partnerships with healthcare distributors.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2015
Headquarters: Daejeon, South Korea
Employees: 31
Open positions: None listed
Dealroom signal: 50.1/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Health Diagnostics, Hard Tech, DT and LS, science-based
Technology: Deep Tech
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
LATE VC✓Equity / VC	Nov 2025	$14M	$57M	Kwangdong Pharmaceutical	↗

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Precision Bio website traffic

Latest recorded traffic for Precision Bio is 10K monthly website visits, down 9.1% over the last three months. Precision Bio's team grew 19.2% over the past year.

Latest monthly visits10K 3-month web change-9.1% 1-year team growth+19.2%

Monthly website visitsApr 2020–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
AIAi-BrainScienceA medical device manufacturing and sales business	Suita-Shi, Japan	Operational	—	$15M	$5.4M
EYEyebotAI-powered vision tests in 90 seconds, prescription-ready	Boston, United States	Operational
PIPicturaBioBuilding instant pathogen tests using super-resolution microscopy and machine learning	Oxford, United Kingdom	Operational
NUNucleinDesigned to be a disposable, all-in-one, self-test for infectious disease diagnosis	Austin, United States	Operational
VMVisby MedicalInstrument-free, single-use, palm-sized PCR diagnostic devices.	San Jose, United States	Operational
NINirtekDetecting unstable coronary plaques before they lead to a heart attack	Melbourne, Australia	Operational
PRProciseDxPoint-of-care testing that delivers precise, high-quality results	San Diego, United States	Acquired
THTHERAPANACEADevotion to Innovation, Compassion for Patients, Artificial Intelligence for Cancer Care	Paris, France	Operational